ストックスクリーナーアプリを入手
7.33
0.96%
0.07
アフターアワーズ：
7.33
Emergent Biosolutions Inc (EBS) 最新ニュース
Emergent BioSolutions Inc (EBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
EBS|Emergent BioSolutions Inc|Price:7.260| - TradingKey
EBS|Emergent BioSolutions Inc|Price:7.260|Chg%:-0.240 - TradingKey
EBS5025997 Bond Risk Profile - TradingView
EBS5025997 Bond Profile — Key Metrics - TradingView
Emergent BioSolutions Inc (EBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Emergent BioSolutions to report Q2 2026 results on August 5 - scanx.trade
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 - The Manila Times
Emergent BioSolutions offers live webcast for Aug. 5 results call - Stock Titan
Emergent BioSolutions (EBS) AGM 2026 Summary - Quartr
Emergent BioSolutions (EBS) Q3 2024 earnings summary - Quartr
Emergent BioSolutions (EBS) Proxy filing Summary - Quartr
Emergent BioSolutions (EBS) Q1 2026 earnings summary - Quartr
Lobbying Update: $510,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Quiver Quantitative
EBS5025998 Bond Profile — Key Metrics - TradingView
EBS5025998 Bond Coupon Profile — Rate & Payments - TradingView
Price to sales forward of Emergent BioSolutions Inc. – LS:A0LC2W - TradingView
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? - Stocktwits
Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by Mutual of America Capital Management LLC - 富途牛牛
Emergent BioSolutions Company Profile & Introduction - Moomoo
Emergent BioSolutions highlights its role in specialty vaccines as investors weigh the long-term out - Ad-hoc-news.de
Insider Sell: Paul Williams Sells 3,000 Shares of Emergent BioSo - GuruFocus
Emergent BioSolutions | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Anthony - Moomoo
Emergent BioSolutions SVP Williams sells $25,200 in common stock By Investing.com - Investing.com Nigeria
Emergent BioSolutions SVP Williams sells $25,200 in common stock - Investing.com
Form 4 Emergent Biosolutions Inc For: 2 July By Investing.com - Investing.com Canada
Emergent BioSolutions (EBS) SVP sells 3,000 shares under plan - Stock Titan
Emergent BioSolutions | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
[144] Emergent BioSolutions Inc. SEC Filing - Stock Titan
Emergent BioSolutions Secures Contract Modification Valued At Approximately USD 52.7 Million From The United States Department Of Health And Human Services To Supply ACAM2000 - marketscreener.com
Emergent BioSolutions Secures New ACAM2000 Biodefense Contract - TipRanks
Emergent BioSolutions (NYSE: EBS) lands $52.7M U.S. ACAM2000 contract - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Emergent BioSolutions (EBS) Secures $52.7M Contract for Smallpox Vaccine Supply - GuruFocus
Emergent BioSolutions wins $52.7m smallpox vaccine contract By Investing.com - Investing.com South Africa
Emergent BioSolutions wins $52.7m smallpox vaccine contract - Investing.com
U.S. government adds $52.7M ACAM2000 order for smallpox preparedness - Stock Titan
Emergent BioSolutions Inc. Actuals & Estimates (NYSE:EBS) - TradingView
Emergent BioSolutions | 8-K: Current report - Moomoo
Emergent BioSolutions Inc. Actuals & Estimates (BOATS:EBS) - TradingView
EBS Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView
Enterprise value to revenue forward of Emergent BioSolutions Inc. – BOATS:EBS - TradingView
Price to sales forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView
Emergent Biosolutions studies intranasal naloxone for opioid overdose response - Traders Union
Emergent BioSolutions Inc (EBS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Emergent BioSolutions Inc (EBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Emergent BioSolutions StockSunday background on the business and risk profile - AD HOC NEWS
Why Emergent’s Narcan nasal spray is becoming a quiet everyday life saver - Ad-hoc-news.de
Emergent BioSolutions Inc (EBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Emergent BioSolutions Inc (EBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Emergent BioSolutions Inc (EBS) Institutional Confidence - TradingKey
Emergent BioSolutions Inc (EBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Emergent BioSolutions Inc (EBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):